Lataa...
GRK5 Gln41Leu polymorphism is not associated with sensitivity to β(1)-adrenergic blockade in humans
AIMS: A common, functionally significant polymorphism in GRK5 (Gln41Leu) encodes a gain-of-function enzyme that enhances desensitization of the β(1)-adrenergic receptor. GRK5 Leu41 has been postulated to confer endogenous ‘genetic β-blockade’ and contribute to an attenuated response to β-blockers in...
Tallennettuna:
| Päätekijät: | , , , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2009
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2820245/ https://ncbi.nlm.nih.gov/pubmed/19842931 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/pgs.09.92 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|